PCN83 Cost Effectiveness Analysis in the Veneto Region of Cabazitaxel Versus Mitoxantrone in Patients with Metastatic Hormone Refractory Prostate Cancer, Previously Treated With a Docetaxel Containing Regimen
- Resource Type
- Abstract
- Source
- In
Value in Health November 2012 15(7):A424-A424 - Subject
- Language
- ISSN
- 1098-3015